Qulipta and Photophobia - a phase IV clinical study of FDA data

Summary:

Photophobia is reported as a side effect among people who take Qulipta (atogepant), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Botox, and have Migraine.

The phase IV clinical study analyzes which people have Photophobia when taking Qulipta. It is created by eHealthMe based on reports of 3,582 people who have side effects when taking Qulipta from the FDA, and is updated regularly.

What is Qulipta?

Qulipta has active ingredients of atogepant. eHealthMe is studying from 3,605 Qulipta users. Check the latest studies of Qulipta.

What is Photophobia?

Photophobia (extreme sensitivity to light) is found to be associated with 1,288 drugs and 1,832 conditions by eHealthMe. Check the latest studies of Photophobia.

On Aug, 04, 2026

3,582 people reported to have side effects when taking Qulipta.
Among them, 16 people (0.45%) have Photophobia.

Among these 16 people:

How long have people been on Qulipta when they have Photophobia? *

What is the gender of people who have Photophobia when taking Qulipta? *

female: 81.25 %
male: 18.75 %

What is the age of people who have Photophobia when taking Qulipta? *

What are other drugs people take besides Qulipta? *

What are other side effects people have besides Photophobia? *

Migraine (headache): 10 people, 62.50%
Headache (pain in head): 8 people, 50.00%
Hyperacusis (disorder in loudness perception): 7 people, 43.75%
Nausea (feeling of having an urge to vomit): 5 people, 31.25%
Drug Ineffective: 3 people, 18.75%
Abdominal Discomfort: 2 people, 12.50%
Cluster Headache (one-sided head pain with tearing): 2 people, 12.50%
Parosmia (distortion of the sense of smell, as in smelling odours that are not present): 2 people, 12.50%
Feeling Abnormal: 2 people, 12.50%
Fatigue (feeling of tiredness): 2 people, 12.50%

What are the existing conditions these people have? *

Migraine (headache): 7 people, 43.75%
High Blood Cholesterol: 2 people, 12.50%
Sleep Disorder: 1 person, 6.25%
Primary Immunodeficiency Syndrome: 1 person, 6.25%
Immunodeficiency Common Variable: 1 person, 6.25%
High Blood Pressure: 1 person, 6.25%
Headache (pain in head): 1 person, 6.25%
Diabetes: 1 person, 6.25%
Bipolar Ii Disorder (characterized by at least one episode of hypomania and at least one episode of major depression): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Qulipta and have Photophobia?

- Check whether Photophobia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Qulipta:

Qulipta (3,605 reports)

Photophobia treatments and more:

Photophobia (21,346 reports)

Browse all side effects of Qulipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Photophobia:

Photophobia (1,288 drugs)

Browse all the conditions that are associated with Photophobia:

Photophobia (1,832 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atogepant (the active ingredients of Qulipta) and Qulipta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.